Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

Here Are 7 Stocks to Avoid Snapping Up in August

By Faizan Farooque, InvestorPlace Contributor
Many of the biggest losers in 2021 enjoyed big runs last year. But keeping up with shifting trends, here are some popular stocks to avoid.

As Long as Corsair’s ESG Issue Persists It Can Hamper CRSR Stock

By Will Ashworth, InvestorPlace Contributor
Corsair Gaming has lost 22% of its value in 2021. One reason CRSR stock is losing altitude has got to do with the composition of its board.

Clover Health Stock Harbors More Weeds Than Daisies

By Dana Blankenhorn, InvestorPlace Contributor
Clover Health claims to be a data-driven Medicare Advantage provider, but every health insurer is a data-driven Medicare Advantage provider.

Despite the Infrastructure Bill, ChargePoint Stock May Take Time to Recover

By Thomas Niel, InvestorPlace Contributor
With its valuation rich, and its federal spending catalyst already priced in, there's little reason to buy CHPT stock at today's prices.

Investors Are Still Looking at Exela Technologies for the Short Squeeze

By Dana Blankenhorn, InvestorPlace Contributor
Exela Technologies has sold $144 million in new shares so far this year, but still has $1.5 billion in debt and a market cap of $157 million. Meanwhile, XELA stock sits in the sights of hungry shorts.

Vaxart Is Another Risky Biotech Stock to Avoid Right Now

By Stavros Georgiadis, CFA, InvestorPlace Contributor
VRXT stock is highly overvalued. Investors are holding out for its Covid-19 vaccine, but it may not be approved in time to boost shares.

4 High Beta Stocks to Avoid on Possibility of a Market Correction

By Faisal Humayun, InvestorPlace Contributor
With the stock market looking frothy, these are four high beta stocks to avoid. Instead, go overweight on defensive stocks.

Avoid Unproven Meta Materials for Now

By Larry Ramer, InvestorPlace Contributor
Meta's new products may not pan out, and meme stocks are likely to continue to weaken, making MMAT stock unattractive.

7 Dividend Stocks to Avoid Until They Start to Shape Up Again

By Louis Navellier and the InvestorPlace Research Staff
When the economy and the markets get confusing, it's a good idea to turn to dividend stocks. Just make sure to pick the right ones.

With Zero Revenue, I Can’t Get Excited About Atossa

By Stavros Georgiadis, CFA, InvestorPlace Contributor
ATOS stock surged briefly in 2021 based on several catalysts, but none of them right now is supportive of its current price and valuation.

Lingering Doubts About the Pandemic Makes Airbnb a Mighty Tough Choice

By Josh Enomoto, InvestorPlace Contributor
With so many unknowns related to the Covid-19 crisis, you shouldn’t touch ABNB stock unless you’re confident about its trajectory.

Workhorse Stock Isn’t Worth Your Investment With Better EV Plays Out There

By Bret Kenwell, InvestorPlace Contributor
How cheap is too cheap? With Workhorse, it's hard to say. Business is too slow and competition is too high for WKHS stock to be attractive.

On SPAC Stage, Pershing Square Tontine Holdings Is Godot to $35 Investors

By Dana Blankenhorn, InvestorPlace Contributor
Since failing to buy a stake in Universal Music Group, Reddit chatter has died down concerning Pershing Square Tontine Holdings. PSTH is back near its original $20 a share price.

Clover Health’s Q2 Gains Are Outweighed by Its Steeper Losses

By Mark R. Hake, CFA
Clover Health's results were unimpressive in the second quarter. CLOV stock is worth just $6.81 at 2.5 times sales until it is profitable.

Coupang Stock Has Risks Well Beyond Its Shaky Balance Sheet

By Dana Blankenhorn, InvestorPlace Contributor
Coupang is focused on growth ahead of profits, even of worker safety. It doesn't own its own cloud either, which is why the "Amazon of Korea" stock is down from its March IPO.

Naked Brand Stock Probably Won’t Rally

By Thomas Niel, InvestorPlace Contributor
The company could be boosted by an e-commerce catalyst. But if you buy NAKD stock, keep in mind that your losses could be substantial.

This Is Why Carnival Stock Continues To Face Big Risks

By Larry Ramer, InvestorPlace Contributor
The outlook of CCL stock has rebounded, but investors should still sell the shares, given the large risks still faced by Carnival.

Clover Stock Has Limited Rebound Potential, So Stay Away

By Thomas Niel, InvestorPlace Contributor
Bottom line: skip out on CLOV stock, and stick with the Reddit favorites stronger prospects.

Avoid Clover Health Stock As Its Losses Mount

By Chris Lau, InvestorPlace Contributor
CLOV stock will continue to fade lower as operating costs rise and the digital transformation is anything but proven.
Load More Articles